Incisive Technologies, based in Melbourne Australia, is developing a novel diagnostic for the oral health sector, which is highly sensitive in detecting early-stage tooth caries. The product is a dental paint, called "BlueCheck" applied to the teeth by an oral health professional (dentist, orthodontist, hygienist, dental assistant, etc) during regular check-ups to detect problems early so that preventive measures can be used, including remineralisation and better patient education. The novel BlueCheck technology is owned and developed by Incisive with patent protection in all major jurisdictions. Incisive is a private Australian company benefitting from international investment and support. As part of its expansion to overseas markets, a strong advocate for preventative tools is required to launch BlueCheck.